GemVax&KAEL Co.Ltd (082270) — Cash Flow-to-Debt Ratio
GemVax&KAEL Co.Ltd (082270) has a Cash Flow-to-Debt Ratio of 0.10x as of December 2025, meaning its operating cash flow of ₩10.34 Billion could theoretically repay 0% of its total liabilities (₩101.65 Billion) in one year. See how much free cash does GemVax&KAEL Co.Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
GemVax&KAEL Co.Ltd Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for GemVax&KAEL Co.Ltd across 13 annual periods. Also explore net asset growth rate of GemVax&KAEL Co.Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for GemVax&KAEL Co.Ltd (2011–2025)
Year-by-year debt coverage analysis for GemVax&KAEL Co.Ltd. For market capitalisation and broader financial context, see 082270 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | ₩1.11 Billion | ₩101.65 Billion | ▲ +104.7% |
| 2024 | -0.23x | ₩-28.37 Billion | ₩121.74 Billion | ▼ -277.3% |
| 2023 | 0.13x | ₩3.57 Billion | ₩27.13 Billion | ▲ +174.7% |
| 2022 | -0.18x | ₩-2.96 Billion | ₩16.79 Billion | ▲ +6.8% |
| 2021 | -0.19x | ₩-3.47 Billion | ₩18.35 Billion | ▼ -131.9% |
| 2020 | 0.59x | ₩13.95 Billion | ₩23.59 Billion | ▲ +5766.7% |
| 2019 | -0.01x | ₩-712.11 Million | ₩68.23 Billion | ▼ -139.8% |
| 2018 | 0.00x | ₩-255.80 Million | ₩58.78 Billion | ▼ -551.3% |
| 2017 | 0.00x | ₩-62.62 Million | ₩93.71 Billion | ▲ +99.3% |
| 2016 | -0.09x | ₩-12.68 Billion | ₩136.25 Billion | ▼ -124.4% |
| 2015 | -0.04x | ₩-5.50 Billion | ₩132.53 Billion | ▼ -124.3% |
| 2014 | 0.17x | ₩10.64 Billion | ₩62.35 Billion | ▲ +32.5% |
| 2011 | 0.13x | ₩7.42 Billion | ₩57.65 Billion | — |